Global network and local vulnerabilities underlie brain atrophy across Parkinson’s disease stages

Andrew Vo(Montreal Neurological Institute and Hospital), Christina Tremblay(Hôpital du Sacré-Cœur de Montréal), Shady Rahayel(Hôpital du Sacré-Cœur de Montréal), Sarah Al–Bachari(University of Manchester), Henk W. Berendse(Amsterdam Neuroscience), Joanna K. Bright(King's College London), Fernando Cendes(Universidade Estadual de Campinas (UNICAMP)), Emile d’Angremont(Amsterdam Neuroscience), John C. Dalrymple‐Alford(University of Canterbury), Ines Debove(University Hospital of Bern), Michiel F. Dirkx(Radboud University Nijmegen), Jason Druzgal(University of Virginia), Gaëtan Garraux(University of Liège), Rick C. Helmich(Radboud University Nijmegen), Michele T Hu(University of Oxford), Neda Jahanshad(University of Southern California), Martin E. Johansson(Radboud University Nijmegen), Johannes Klein(Wellcome Centre for Integrative Neuroimaging), Max A. Laansma(Amsterdam Neuroscience), Corey T. McMillan(University of Pennsylvania), Tracy R. Melzer(University of Canterbury), Bratislav Mišić(Montreal Neurological Institute and Hospital), Philip Mosley(QIMR Berghofer Medical Research Institute), Conor Owens‐Walton(University of Southern California), Laura M. Parkes(Manchester Academic Health Science Centre), Clelia Pellicano(Fondazione Santa Lucia), Fabrizio Piras(Fondazione Santa Lucia), Kathleen L. Poston(Centre for Movement Disorders), Mario Rango(Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico), Christian Rummel(University of Bern), Petra Schwingenschuh(Medical University of Graz), Melanie Suette(Medical University of Graz), Paul M. Thompson(University of Southern California), Duygu Tosun(University of California, San Francisco), Chih‐Chien Tsai(Chang Gung University), Tim D. van Balkom(Amsterdam Neuroscience), Odile A. van den Heuvel(Amsterdam Neuroscience), Ysbrand D. van der Werf(Amsterdam Neuroscience), Eva M. van Heese(Amsterdam Neuroscience), Chris Vriend(Amsterdam Neuroscience), Jiun‐Jie Wang(Chang Gung University), Roland Wiest(University of Bern), Clarissa Lin Yasuda(Universidade Estadual de Campinas (UNICAMP)), Alain Dagher(Montreal Neurological Institute and Hospital)
Brain
November 13, 2025
Cited by 2Open Access
Full Text

Abstract

Parkinson's disease (PD) is associated with extensive structural brain changes. Recent work has proposed that the spatial pattern of disease pathology is shaped by both network spread and local vulnerability. However, only few studies assessed these biological frameworks in large patient samples across disease stages. Analyzing the largest imaging cohort in PD to date (n = 3,096 patients), we investigated the roles of network architecture and local brain features by relating regional abnormality maps to normative profiles of connectivity, intrinsic networks, cytoarchitectonics, neurotransmitter receptor densities, and gene expression. We found widespread cortical and subcortical atrophy in PD to be associated with advancing disease stage, longer time since diagnosis, and poorer global cognition. Structural brain connectivity best explained cortical atrophy patterns in PD and across disease stages. These patterns were robust among individual patients. The precuneus, lateral temporal cortex, and amygdala were identified as likely network-based epicentres, with high convergence across disease stages. Individual epicentres varied significantly among patients, yet they consistently localized to the default mode and limbic networks. Furthermore, we showed that regional overexpression of genes implicated in synaptic structure and signalling conferred increased susceptibility to brain atrophy in PD. In summary, this study demonstrates in a well-powered sample that structural brain abnormalities in PD across disease stages and within individual patients are influenced by both network spread and local vulnerability.


Related Papers

No related papers found

Powered by citation graph analysis